APRIL BROOKS: Open Payments
NPI 1023251386 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 18 payments from 10 companies in 2025. Trend: 2023 $451 · 2024 $199 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 6 | $98 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Hologic Sales and Service, LLC | 1 | $35 |
| Organon LLC | 2 | $35 |
| Exeltis, USA Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Solventum Corporation | 1 | $17 |
Products named: ZURZUVAE, NOVASURE, NEXPLANON, SLYND, GEMTESA, Lynkuet, Qelbree, Mirena.
Industry payments across AL — which companies pay providers there.
